Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: Findings, results, and indications

被引:35
|
作者
Kim, H. Jeffrey [1 ,2 ,6 ]
Hagan, Marygrace [3 ]
Butman, John A. [4 ]
Baggenstos, Martin [3 ]
Brewer, Carmen [1 ,2 ]
Zalewski, Christopher [1 ,2 ]
Linehan, W. Marston [5 ]
Lonser, Russell R. [3 ]
机构
[1] Natl Inst Deafness & Other Commun Disorders, Off Clin Director, NIH, Bethesda, MD USA
[2] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Bethesda, MD USA
[3] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA
[4] NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA
[5] NIH, Urol Oncol Branch, Natl Canc Ctr, Bethesda, MD 20892 USA
[6] Georgetown Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Washington, DC 20007 USA
基金
美国国家卫生研究院;
关键词
Endolymphatic sac tumor; von Hippel-Lindau; hearing loss; outcome; vertigo; surgery; MORBID HEARING-LOSS; COCHLEAR IMPLANTATION; TEMPORAL BONE; ADENOCARCINOMA; ORIGIN; GENE;
D O I
10.1002/lary.23646
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: To define the surgical treatment and outcomes of von Hippel-Lindau (VHL) disease-associated endolymphatic sac tumors (ELSTs), we analyzed consecutive VHL patients who underwent ELST resection. Study Design: Retrospective investigation of consecutive VHL patients who underwent resection of ELSTs at a clinical research center between 1999 and 2010. Methods: Analysis of serial clinical examinations, audiograms, imaging studies, and operative findings were analyzed. Results: Thirty-one consecutive patients with ELSTs (15 males, 16 females) underwent resection of 33 tumors (mean follow-up, 49.9 +/- 48.0 months; range, 1.0116 months). One patient had bilateral ELST resections and one patient underwent reoperation for recurrence. Mean age at surgery was 38.2 +/- 10.2 years (range, 1267 years). Whereas 29 ears (88%) had direct radiographic evidence of an ELST, four ears (12%) did not. Mean tumor size was 1.3 +/- 1.1 cm (range, 0.25.2 cm). Whereas two patients (two ears, 6%) were asymptomatic, 29 patients (31 ears, 94% of ears) had associated audiovestibular symptoms, including sensorineural hearing loss (28 ears, 84%), tinnitus (24 ears,73%), and vertigo (21 patients, 68%). Postoperatively, hearing was stabilized (27) or improved (three) in 97% of 31 ears. Complete tumor resection was achieved in 30 ears (91% of 33 ears). Complications included cerebrospinal fluid leak in two ears (6%) and transient lower cranial nerve palsy in one ear (3%). Conclusions: Surgical resection of ELSTs can be performed with hearing preservation and a reduction in audiovestibular dysfunction. Early surgical resection can prevent or decrease disabling audiovestibular symptoms, enhance the opportunity for complete resection, and preserve hearing. Laryngoscope, 2012
引用
收藏
页码:477 / 483
页数:7
相关论文
共 50 条
  • [41] Unsuspected pheochromocytoma: von Hippel-Lindau disease
    Gurunathan, U
    Korula, G
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2004, 16 (01) : 26 - 28
  • [42] Genetic Analysis of von Hippel-Lindau Disease
    Nordstrom-O'Brien, Morgan
    van der Luijt, Rob B.
    van Rooijen, Ellen
    van den Ouweland, Ans M.
    Majoor-Krakauer, Danielle F.
    Lolkema, Martijn P.
    van Brussel, Aram
    Voest, Emile E.
    Giles, Rachel H.
    HUMAN MUTATION, 2010, 31 (05) : 521 - 537
  • [43] Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease
    Shively, Sharon B.
    Falke, Eric A.
    Li, Jie
    Tran, Maxine G. B.
    Thompson, Eli R.
    Maxwell, Patrick H.
    Roessler, Erich
    Oldfield, Edward H.
    Lonser, Russell R.
    Vortmeyer, Alexander O.
    MODERN PATHOLOGY, 2011, 24 (08) : 1023 - 1030
  • [44] Spinal paraganglioma as unusual finding in von Hippel-Lindau disease
    Klingler, Jan-Helge
    Elsheikh, Samer
    Doostkam, Soroush
    Krueger, Marie T.
    Blass, Bianca-Ioana
    Steiert, Christine
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 77 : 217 - 221
  • [45] Von Hippel-Lindau Disease: Current Challenges and Future Prospects
    Glasker, Sven
    Vergauwen, Evelynn
    Koch, Christian A.
    Kutikov, Alexander
    Vortmeyer, Alexander O.
    ONCOTARGETS AND THERAPY, 2020, 13 : 5669 - 5690
  • [46] Von Hippel-Lindau syndrome: molecular mechanisms of the disease
    María J. Calzada
    Clinical and Translational Oncology, 2010, 12 : 160 - 165
  • [47] Unusual ocular presentation of von Hippel-Lindau disease
    Valenzuela, A
    Druker, H
    Malkin, D
    Gallie, B
    Héon, E
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2005, 40 (05): : 593 - 597
  • [48] Pituitary stalk hemangioblastomas in von Hippel-Lindau disease
    Lonser, Russell R.
    Butman, John A.
    Kiringoda, Ruwan
    Song, Debbie
    Oldfield, Edward H.
    JOURNAL OF NEUROSURGERY, 2009, 110 (02) : 350 - 353
  • [49] Guidelines for routine management of von Hippel-Lindau disease
    Decq, P
    NEUROCHIRURGIE, 1998, 44 (04) : 273 - 274
  • [50] Clear cell chondrosarcoma in Von Hippel-Lindau disease
    Koen M. A. Dreijerink
    Rachel S. van Leeuwaarde
    Wenzel M. Hackeng
    Rachel H. Giles
    Wendy W. J. de Leng
    Paul C. Jutte
    Albert J. H. Suurmeijer
    Bernadette P. M. van Nesselrooij
    Lodewijk A. A. Brosens
    Familial Cancer, 2020, 19 : 41 - 45